A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Clinical trial NCT06161584 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06161584
- Sponsor
- Apellis Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-28
- Primary completion
- 2027-06-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.